Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,046,302
+$5,733,007 QoQ
Shares Held
147,054
+29.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#112
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $27,851,957,097 across 16 Drug Manufacturers - General names. NVS ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,320,446 | $5,909,959,895 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
39,819,151 | $5,030,751,525 | |
| 3 | LLY |
ELI LILLY & Co
|
3,694,152 | $4,430,877,092 | |
| 4 | JNJ |
Johnson & Johnson
|
15,674,093 | $3,980,749,389 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,611,171 | $2,391,535,466 | |
| 6 | AZN |
Astrazeneca PLC
|
10,177,013 | $1,929,765,193 | |
| 7 | ABBV |
AbbVie Inc.
|
7,114,782 | $1,790,363,732 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,033,480 | $923,849,108 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,046,302 | 147,054 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $17,313,295 | 113,344 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $24,220,586 | 175,677 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $22,959,959 | 179,039 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $24,196,916 | 199,958 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $21,465,362 | 192,549 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $23,329,293 | 239,742 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $23,317,543 | 202,726 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $25,857,109 | 242,881 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $23,478,594 | 242,723 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $27,011,089 | 267,516 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $30,042,893 | 294,943 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $32,870,523 | 325,741 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $36,606,156 | 397,893 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $30,375,232 | 334,824 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $27,731,259 | 364,837 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $28,035,048 | 331,658 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $28,753,392 | 327,674 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $25,496,628 | 291,490 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $30,837,683 | 377,081 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $46,886,410 | 513,880 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $63,526,854 | 743,178 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $92,192,196 | 976,302 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $136,215,273 | 1,566,413 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $139,759,632 | 1,600,179 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $160,579,372 | 1,947,597 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||